{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:00:35Z","timestamp":1790312435309,"version":"4.1.0"},"reference-count":83,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016947","name":"Swim Across America","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009729","name":"Ludwig Institute for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009729","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014547","name":"Parker Institute for Cancer Immunotherapy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014547","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.celrep.2026.117443","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T16:29:39Z","timestamp":1780072179000},"page":"117443","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tumor-intrinsic expression of signal regulatory protein \u03b1 contributes to the suppression of anti-tumor immune responses"],"prefix":"10.1016","volume":"45","author":[{"given":"Chien-Huan","family":"Weng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chana","family":"Schochet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Panneton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anais","family":"Assouvie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shabnam","family":"Eghbali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Monette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cailian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yacine","family":"Marouf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Levi","family":"Mangarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Morgado-Palacin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parwiz","family":"Abrahimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan F.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher S.","family":"Hackett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Hamadene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela M.","family":"Holland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jedd D.","family":"Wolchok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1518-5111","authenticated-orcid":false,"given":"Taha","family":"Merghoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2026.117443_bib1","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1056\/NEJMra2034861","article-title":"Recent Advances in the Treatment of Melanoma","volume":"384","author":"Curti","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.celrep.2026.117443_bib2","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1084\/jem.182.2.459","article-title":"CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation","volume":"182","author":"Krummel","year":"1995","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.celrep.2026.117443_bib3","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S1074-7613(00)80089-8","article-title":"Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor","volume":"11","author":"Nishimura","year":"1999","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2026.117443_bib4","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1056\/NEJMoa1302369","article-title":"Nivolumab plus ipilimumab in advanced melanoma","volume":"369","author":"Wolchok","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.celrep.2026.117443_bib5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa2407417","article-title":"Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma","volume":"392","author":"Wolchok","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.celrep.2026.117443_bib6","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2009.05.046","article-title":"CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis","volume":"138","author":"Jaiswal","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2026.117443_bib7","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/386181a0","article-title":"A family of proteins that inhibit signalling through tyrosine kinase receptors","volume":"386","author":"Kharitonenkov","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2026.117443_bib8","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nri1859","article-title":"The SIRP family of receptors and immune regulation","volume":"6","author":"Barclay","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.celrep.2026.117443_bib9","doi-asserted-by":"crossref","first-page":"6887","DOI":"10.1128\/MCB.16.12.6887","article-title":"A novel membrane glycoprotein, SHPS-1, that binds the SH2-domain-containing protein tyrosine phosphatase SHP-2 in response to mitogens and cell adhesion","volume":"16","author":"Fujioka","year":"1996","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.celrep.2026.117443_bib10","doi-asserted-by":"crossref","first-page":"27652","DOI":"10.1074\/jbc.271.44.27652","article-title":"Characterization of a 115-kDa protein that binds to SH-PTP2, a protein-tyrosine phosphatase with Src homology 2 domains, in Chinese hamster ovary cells","volume":"271","author":"Noguchi","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.celrep.2026.117443_bib11","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.4049\/jimmunol.174.4.2004","article-title":"Negative regulation of phagocytosis in macrophages by the CD47-SHPS-1 system","volume":"174","author":"Okazawa","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.celrep.2026.117443_bib12","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1084\/jem.193.7.855","article-title":"CD47-signal regulatory protein alpha (SIRPalpha) regulates Fcgamma and complement receptor-mediated phagocytosis","volume":"193","author":"Oldenborg","year":"2001","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.celrep.2026.117443_bib13","doi-asserted-by":"crossref","first-page":"22719","DOI":"10.1074\/jbc.273.35.22719","article-title":"High expression of inhibitory receptor SHPS-1 and its association with protein-tyrosine phosphatase SHP-1 in macrophages","volume":"273","author":"Veillette","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.celrep.2026.117443_bib14","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1083\/jcb.200708043","article-title":"Inhibition of \u201cself\u201d engulfment through deactivation of myosin-II at the phagocytic synapse between human cells","volume":"180","author":"Tsai","year":"2008","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.celrep.2026.117443_bib15","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1183850","article-title":"Inhibition of SIRPalpha in dendritic cells potentiates potent antitumor immunity","volume":"5","author":"Liu","year":"2016","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.celrep.2026.117443_bib16","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1126\/science.288.5473.2051","article-title":"Role of CD47 as a marker of self on red blood cells","volume":"288","author":"Oldenborg","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.celrep.2026.117443_bib17","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.immuni.2015.08.021","article-title":"Splenic Dendritic Cells Survey Red Blood Cells for Missing Self-CD47 to Trigger Adaptive Immune Responses","volume":"43","author":"Yi","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2026.117443_bib18","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1189\/jlb.2MR0317-105R","article-title":"Shp1 function in myeloid cells","volume":"102","author":"Abram","year":"2017","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.celrep.2026.117443_bib19","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s41392-022-01038-3","article-title":"Targeting protein phosphatases for the treatment of inflammation-related diseases: From signaling to therapy","volume":"7","author":"Pan","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.celrep.2026.117443_bib20","doi-asserted-by":"crossref","first-page":"6109","DOI":"10.1172\/JCI135528","article-title":"Selective SIRPalpha blockade reverses tumor T cell exclusion and overcomes cancer immunotherapy resistance","volume":"130","author":"Gauttier","year":"2020","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.celrep.2026.117443_bib21","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1038\/nm.3931","article-title":"CD47 blockade triggers T cell-mediated destruction of immunogenic tumors","volume":"21","author":"Liu","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2026.117443_bib22","doi-asserted-by":"crossref","first-page":"11103","DOI":"10.1073\/pnas.1305569110","article-title":"Anti-CD47 antibody-mediated phagocytosis of cancer by macrophages primes an effective antitumor T-cell response","volume":"110","author":"Tseng","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2026.117443_bib23","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1158\/1078-0432.CCR-14-2520","article-title":"Molecular Pathways: Activating T Cells after Cancer Cell Phagocytosis from Blockade of CD47 \u201cDon\u2019t Eat Me\u201d Signals","volume":"21","author":"McCracken","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.celrep.2026.117443_bib24","doi-asserted-by":"crossref","first-page":"6662","DOI":"10.1073\/pnas.1121623109","article-title":"The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors","volume":"109","author":"Willingham","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2026.117443_bib25","article-title":"CD47-SIRPalpha-targeted therapeutics: status and prospects","volume":"13","author":"Maute","year":"2022","journal-title":"Immunooncol. Technol."},{"key":"10.1016\/j.celrep.2026.117443_bib26","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/CMR.0000000000000629","article-title":"Evolutionarily conserved resistance to phagocytosis observed in melanoma cells is insensitive to upregulation of pro-phagocytic signals and to CD47 blockade","volume":"30","author":"Anderson","year":"2020","journal-title":"Melanoma Res."},{"key":"10.1016\/j.celrep.2026.117443_bib27","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.ccell.2022.10.012","article-title":"Tumor-intrinsic SIRPA promotes sensitivity to checkpoint inhibition immunotherapy in melanoma","volume":"40","author":"Zhou","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2026.117443_bib28","first-page":"A1191","article-title":"1148 Signal-regulatory protein alpha (SIRP\u03b1) confers tumor cell resistance to anti-tumor immunity","volume":"10","author":"Weng","year":"2022","journal-title":"J. ImmunoTher. Cancer"},{"key":"10.1016\/j.celrep.2026.117443_bib29","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.89140","article-title":"Anti-SIRPalpha antibodies as a potential new tool for cancer immunotherapy","volume":"2","author":"Yanagita","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.celrep.2026.117443_bib30","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/j.1365-2133.2010.10176.x","article-title":"CXCL10 reduces melanoma proliferation and invasiveness in vitro and in vivo","volume":"164","author":"Antonicelli","year":"2011","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.celrep.2026.117443_bib31","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1038\/leu.2014.121","article-title":"Heparanase enhances myeloma progression via CXCL10 downregulation","volume":"28","author":"Barash","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.celrep.2026.117443_bib32","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s00262-001-0231-9","article-title":"Improved survival in tumor-bearing SCID mice treated with interferon-gamma-inducible protein 10 (IP-10\/CXCL10)","volume":"50","author":"Arenberg","year":"2001","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.celrep.2026.117443_bib33","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.ccell.2017.04.003","article-title":"Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy","volume":"31","author":"Spranger","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2026.117443_bib34","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003521","article-title":"Immune cell and tumor cell-derived CXCL10 is indicative of immunotherapy response in metastatic melanoma","volume":"9","author":"Reschke","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.celrep.2026.117443_bib35","doi-asserted-by":"crossref","first-page":"969","DOI":"10.4049\/jimmunol.1002099","article-title":"Ets-1 maintains IL-7 receptor expression in peripheral T cells","volume":"186","author":"Grenningloh","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.celrep.2026.117443_bib36","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41590-022-01194-2","article-title":"TCF-1: a maverick in T cell development and function","volume":"23","author":"Gounari","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celrep.2026.117443_bib37","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.immuni.2019.09.013","article-title":"TCF-1-Centered Transcriptional Network Drives an Effector versus Exhausted CD8 T Cell-Fate Decision","volume":"51","author":"Chen","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2026.117443_bib38","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/j.cell.2020.05.017","article-title":"Intratumoral CD4(+) T Cells Mediate Anti-tumor Cytotoxicity in Human Bladder Cancer","volume":"181","author":"Oh","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2026.117443_bib39","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41586-021-04390-6","article-title":"Decade-long leukaemia remissions with persistence of CD4(+) CAR T cells","volume":"602","author":"Melenhorst","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2026.117443_bib40","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ccell.2022.03.006","article-title":"Neoantigen-specific CD4(+) T cells in human melanoma have diverse differentiation states and correlate with CD8(+) T cell, macrophage, and B cell function","volume":"40","author":"Veatch","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2026.117443_bib41","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/s41586-022-04682-5","article-title":"Landscape of helper and regulatory antitumour CD4(+) T cells in melanoma","volume":"605","author":"Oliveira","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2026.117443_bib42","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/s41586-023-06199-x","article-title":"CD4(+) T cell-induced inflammatory cell death controls immune-evasive tumours","volume":"618","author":"Kruse","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2026.117443_bib43","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1016\/j.ccell.2023.08.001","article-title":"Tumor immunogenicity dictates reliance on TCF1 in CD8(+) T cells for response to immunotherapy","volume":"41","author":"Escobar","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2026.117443_bib44","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1084\/jem.20180684","article-title":"High-dimensional single cell analysis identifies stem-like cytotoxic CD8(+) T cells infiltrating human tumors","volume":"215","author":"Brummelman","year":"2018","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.celrep.2026.117443_bib45","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.immuni.2018.12.021","article-title":"Intratumoral Tcf1(+)PD-1(+)CD8(+) T Cells with Stem-like Properties Promote Tumor Control in Response to Vaccination and Checkpoint Blockade Immunotherapy","volume":"50","author":"Siddiqui","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2026.117443_bib46","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.immuni.2018.11.014","article-title":"Checkpoint Blockade Immunotherapy Induces Dynamic Changes in PD-1(-)CD8(+) Tumor-Infiltrating T Cells","volume":"50","author":"Kurtulus","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2026.117443_bib47","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41586-021-03862-z","article-title":"Functional HPV-specific PD-1(+) stem-like CD8 T cells in head and neck cancer","volume":"597","author":"Eberhardt","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2026.117443_bib48","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.cell.2018.10.038","article-title":"Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma","volume":"175","author":"Sade-Feldman","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2026.117443_bib49","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/s41590-019-0312-6","article-title":"Subsets of exhausted CD8(+) T cells differentially mediate tumor control and respond to checkpoint blockade","volume":"20","author":"Miller","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celrep.2026.117443_bib50","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1096\/fj.03-0170fje","article-title":"Regulation of TNF-alpha- and IFN-gamma-induced CXCL10 expression: participation of the airway smooth muscle in the pulmonary inflammatory response in chronic obstructive pulmonary disease","volume":"18","author":"Hardaker","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.celrep.2026.117443_bib51","doi-asserted-by":"crossref","first-page":"5238","DOI":"10.1073\/pnas.87.14.5238","article-title":"A macrophage mRNA selectively induced by gamma-interferon encodes a member of the platelet factor 4 family of cytokines","volume":"87","author":"Farber","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2026.117443_bib52","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/00024382-200206000-00013","article-title":"CXC chemokine expression after stimulation with interferon-gamma in primary rat hepatocytes in culture","volume":"17","author":"Ren","year":"2002","journal-title":"Shock"},{"key":"10.1016\/j.celrep.2026.117443_bib53","first-page":"2780","article-title":"Interferon-gamma and CXC chemokine induction by interleukin 12 in renal cell carcinoma","volume":"5","author":"Bukowski","year":"1999","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.celrep.2026.117443_bib54","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1046\/j.1523-1747.1999.00581.x","article-title":"Human IP-9: A keratinocyte-derived high affinity CXC-chemokine ligand for the IP-10\/Mig receptor (CXCR3)","volume":"112","author":"Tensen","year":"1999","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.celrep.2026.117443_bib55","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s004030050314","article-title":"Chemokine IP-10 expression in cultured human keratinocytes","volume":"290","author":"Boorsma","year":"1998","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.celrep.2026.117443_bib56","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1359-6101(97)00015-4","article-title":"The immunobiology of interferon-gamma inducible protein 10 kD (IP-10): a novel, pleiotropic member of the C-X-C chemokine superfamily","volume":"8","author":"Neville","year":"1997","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.celrep.2026.117443_bib57","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s004410000274","article-title":"Induction of the synthesis of the C-X-C chemokine interferon-gamma-inducible protein-10 in experimental canine endotoxemia","volume":"302","author":"Frangogiannis","year":"2000","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.celrep.2026.117443_bib58","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1158\/1078-0432.CCR-19-1868","article-title":"Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade","volume":"26","author":"House","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.celrep.2026.117443_bib59","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1158\/0008-5472.CAN-08-2281","article-title":"Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment","volume":"69","author":"Harlin","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.celrep.2026.117443_bib60","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.4049\/jimmunol.2100266","article-title":"Non-Lyn Src Family Kinases Activate SIRPalpha-SHP-1 to Inhibit PI3K-Akt2 and Dampen Proinflammatory Macrophage Polarization","volume":"207","author":"Shi","year":"2021","journal-title":"J. Immunol."},{"key":"10.1016\/j.celrep.2026.117443_bib61","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.tcb.2008.12.001","article-title":"Functions and molecular mechanisms of the CD47-SIRPalpha signalling pathway","volume":"19","author":"Matozaki","year":"2009","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.celrep.2026.117443_bib62","doi-asserted-by":"crossref","DOI":"10.1186\/bcr3457","article-title":"Novel sorafenib analogues induce apoptosis through SHP-1 dependent STAT3 inactivation in human breast cancer cells","volume":"15","author":"Liu","year":"2013","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.celrep.2026.117443_bib63","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s00109-017-1549-x","article-title":"Sequential combination of docetaxel with a SHP-1 agonist enhanced suppression of p-STAT3 signaling and apoptosis in triple negative breast cancer cells","volume":"95","author":"Liu","year":"2017","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.celrep.2026.117443_bib64","doi-asserted-by":"crossref","first-page":"468","DOI":"10.20892\/j.issn.2095-3941.2020.0501","article-title":"SHP-1 acts as a tumor suppressor by interacting with EGFR and predicts the prognosis of human breast cancer","volume":"19","author":"Geng","year":"2021","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.celrep.2026.117443_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2021.112914","article-title":"CLEC12B suppresses lung cancer progression by inducing SHP-1 expression and inactivating the PI3K\/AKT signaling pathway","volume":"409","author":"Chi","year":"2021","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.celrep.2026.117443_bib66","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/cr.2010.183","article-title":"NF-kappaB and STAT3 - key players in liver inflammation and cancer","volume":"21","author":"He","year":"2011","journal-title":"Cell Res."},{"key":"10.1016\/j.celrep.2026.117443_bib67","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1128\/MCB.19.3.2416","article-title":"Shp-2 tyrosine phosphatase functions as a negative regulator of the interferon-stimulated Jak\/STAT pathway","volume":"19","author":"You","year":"1999","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.celrep.2026.117443_bib68","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.gendis.2020.06.005","article-title":"The Nuclear Factor Kappa B (NF-kB) signaling in cancer development and immune diseases","volume":"8","author":"Zinatizadeh","year":"2021","journal-title":"Genes Dis."},{"key":"10.1016\/j.celrep.2026.117443_bib69","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa9223","article-title":"Genetic variants associated with autoimmunity drive NFkappaB signaling and responses to inflammatory stimuli","volume":"7","author":"Housley","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.celrep.2026.117443_bib70","doi-asserted-by":"crossref","first-page":"5088","DOI":"10.1038\/s41388-018-0337-6","article-title":"Myeloid-restricted ablation of Shp2 restrains melanoma growth by amplifying the reciprocal promotion of CXCL9 and IFN-gamma production in tumor microenvironment","volume":"37","author":"Xiao","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.celrep.2026.117443_bib71","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/s43018-023-00691-z","article-title":"Sirpalpha on tumor-associated myeloid cells restrains antitumor immunity in colorectal cancer independent of its interaction with CD47","volume":"5","author":"Huang","year":"2024","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.celrep.2026.117443_bib72","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.cell.2009.05.045","article-title":"CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells","volume":"138","author":"Majeti","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2026.117443_bib73","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1158\/0008-5472.CAN-10-2238","article-title":"Therapeutic antibody targeting of CD47 eliminates human acute lymphoblastic leukemia","volume":"71","author":"Chao","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.celrep.2026.117443_bib74","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.cell.2010.07.044","article-title":"Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma","volume":"142","author":"Chao","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2026.117443_bib75","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.canlet.2015.02.036","article-title":"Antibody mediated therapy targeting CD47 inhibits tumor progression of hepatocellular carcinoma","volume":"360","author":"Xiao","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.celrep.2026.117443_bib76","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.immuni.2017.07.016","article-title":"Dendritic Cells but Not Macrophages Sense Tumor Mitochondrial DNA for Cross-priming through Signal Regulatory Protein alpha Signaling","volume":"47","author":"Xu","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2026.117443_bib77","article-title":"Pre-Clinical Development of a Humanized Anti-CD47 Antibody with Anti-Cancer Therapeutic Potential","volume":"10","author":"Liu","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.celrep.2026.117443_bib78","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2017.7","article-title":"Anti-leukemic activity and tolerability of anti-human CD47 monoclonal antibodies","volume":"7","author":"Pietsch","year":"2017","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.celrep.2026.117443_bib79","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1186\/s40425-019-0772-0","article-title":"Functional characterization of the selective pan-allele anti-SIRPalpha antibody ADU-1805 that blocks the SIRPalpha-CD47 innate immune checkpoint","volume":"7","author":"Voets","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.celrep.2026.117443_bib80","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1200\/JCO.21.00612","article-title":"Lifileucel, a Tumor-Infiltrating Lymphocyte Therapy, in Metastatic Melanoma","volume":"39","author":"Sarnaik","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.celrep.2026.117443_bib81","article-title":"TYRP1 directed CAR T cells control tumor progression in preclinical melanoma models","volume":"32","author":"Hackett","year":"2024","journal-title":"Mol. Ther. Oncol."},{"key":"10.1016\/j.celrep.2026.117443_bib82","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1038\/s41467-024-45221-2","article-title":"CAR-T cell therapy targeting surface expression of TYRP1 to treat cutaneous and rare melanoma subtypes","volume":"15","author":"Jilani","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2026.117443_bib83","article-title":"Mouse CD8(+) T Cell Migration in vitro and CXCR3 Internalization Assays","volume":"7","author":"Da Silva","year":"2017","journal-title":"Bio. Protoc."}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124726005218?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124726005218?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T04:40:09Z","timestamp":1790311209000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124726005218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":83,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2211124726005218"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2026.117443","relation":{},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor-intrinsic expression of signal regulatory protein \u03b1 contributes to the suppression of anti-tumor immune responses","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2026.117443","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117443"}}